Abstract
Purpose
To describe the role of Positron Emission Tomography/Computed Tomography (PET/CT), Magnetic Resonance Imaging (MRI), sonography, and mammography in patients with inflammatory breast cancer (IBC).
Materials and methods
Patients who had been newly diagnosed with IBC and who had undergone mammography, sonography, MRI, PET/CT, or a combination of these were included in this study. The visibility of breast parenchymal lesion (BPLs), skin abnormalities, regional (axillary, supraclavicular, or internal mammary) nodal disease, and distant metastatic disease was documented with the imaging techniques.
Results
Eighty patients (median age, 51 years, [range, 25–78 years]) were included in this study: 75 (94%) had undergone mammography, 76 (95%) sonography, 33 (41%) MRI, and 24 (30%) PET/CT. A primary BPL was found in 60 patients (80%) on mammography (mass or calcifications), 72 (95%) on sonography (mass or architectural distortion), 23 (96%) on PET/CT (hypermetabolic BPL), and 33 (100%) on MRI (enhancing BPL). Regional axillary nodal disease was found in 74 patients (93%) by histologic or cytologic examination, in 71 patients (93%) on sonography, in 21 (88%) on PET/CT, in 29 (88%) on MRI, and in 34 (45%) on mammography. Distant metastases in the bone, liver, and contralateral lymph nodes were diagnosed in nine patients (38%) on PET/CT.
Conclusion
MRI was the most accurate imaging technique in detecting a primary BPL in IBC patients. Sonography can be useful in diagnosing regional nodal disease. PET/CT provides additional information on distant metastasis, and it should be considered in the initial staging of IBC.
Similar content being viewed by others
References
Levine PH, Steinhorn SC, Ries LG, Aron JL (1985) Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst 74:291–297
Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD (1998) Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer 82:2366–2372
Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97:966–975
Lee B, Tannenbaum N (1924) Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of memorial hospital. Surg Gynecol Obstet 39:580–585
Jaiyesimi IA, Buzdar AU, Hortobagyi G (1992) Inflammatory breast cancer: a review. J Clin Oncol 10:1014–1024
Dirix LY, Dam PV, Prove A et al (2006) Inflammatory breast cancer: current understanding. Curr Opin Oncol 18:563–571
Dershaw DD, Moore MP, Liberman L et al (1994) Inflammatory breast carcinoma: mammographic findings. Radiology 190:831–834
Droulias CA, Sewell CW, McSweeney MB et al (1976) Inflammatory carcinoma of the breast: a correlation of clinical, radiologic and pathologic findings. Ann Surg 184:217–222
Gunhan-Bilgen I, Ustun EE, Memis A (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223:829–838
Kushwaha AC, Whitman GJ, Stelling CB et al (2000) Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol 174:535–538
Caumo F, Gaioni MB, Bonetti F et al (2005) Occult inflammatory breast cancer: review of clinical, mammographic, US and pathologic signs. Radiol Med (Torino) 109:308–320
Tardivon AA, Viala J, CorvellecRudelli A et al (1997) Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol 24:124–130
Lee KW, Chung SY, Yang I et al (2005) Inflammatory breast cancer: imaging findings. Clin Imaging 29:22–25
Chow CK (2005) Imaging in inflammatory breast carcinoma. Breast Dis 22:45–54
Belli P, Costantini M, Romani M et al (2002) Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays 27:299–305
Rieber A, Tomczak RJ, Mergo PJ et al (1997) MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput Assist Tomogr 21:128–132
Baslaim MM, Bakheet SM, Bakheet R et al (2003) 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg 27:1099–1104
Johnson MS, Gonzales MN, Bizila S (2005) Responsible conduct of Radiology research. Part V. The Health Insurance Portability and Accountability Act and Research. Radiology 237:757–764
American College of Radiology (ACR) (2003) ACR BI-RADS – Mammography. In ACR breast imaging reporting and data system, breast imaging atlas. American College of Radiology, Reston, VA
American College of Radiology (ACR). (2003) ACR BI-RADS – Ultrasound. In ACR breast imaging reporting and data system, breast imaging atlas. American College of Radiology, Reston, VA
Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C (1996) High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 16:241–246
Vlastos G, Fornage BD, Mirza NQ et al (2000) The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherap. Am J Surg 179:446–452
Scatarige JC, Hamper UM, Sheth S, Allen HA III (1989) Parasternal sonography of the internal mammary vessels: technique, normal anatomy, and lymphadenopathy. Radiology 172:453–457
American College of Radiology (ACR) (2003) ACR BI-RADS – Magnetic Resonance Imaging. In ACR breast imaging reporting and data system, breast imaging atlas. American College of Radiology, Reston, VA
Mawlawi O, Podoloff DA, Kohlmyer S et al (2004) Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 45:1734–1742
Mawlawi O, Podoloff D, Macapinlac H (2003) Evaluation of clinical image quality and lesion detectability of the GE Discovery ST (DST) PET/CT scanner. J Nucl Med 44:Supplement 282 p
Elston CW, Ellis IO (1998) Assessment of histologic grade. In: Elston CW, Ellis IO (eds) The breast, vol 13. Churchill Livingstone, Edinburgh, New York, pp 356–384
Boyd NF, Byng JW, Jong RA et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670–675
Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230:29–41
Anderson WF, Chu KC, Chang S (2003) Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol 21:2254–2259
Walshe JM, Swain SM (2005) Clinical aspects of inflammatory breast cancer. Breast Dis 22:35–44
Fueger BJ, Weber WA, Quon A et al (2005) Performance of 2-Deoxy-2-[F-18]fluoro-D-glucose Positron Emission Tomography and Integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol 7:369–376
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, W.T., Le-Petross, H.T., Macapinlac, H. et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109, 417–426 (2008). https://doi.org/10.1007/s10549-007-9671-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-007-9671-z